|
Upon determination of classes to be reviewed, the department
announces the review to the affected manufacturers by E-mail,
based on the department’s official Manufacturer
Contact List, and posts an announcement on the department’s
Web site. The department establishes a review schedule
and will announce a due date for offers when the class
announcement is made. During the review period, the department’s
clinical contractor reviews clinical factors and makes
recommendations to the department. Upon receipt of the
clinical recommendations, the department then makes PDL
recommendations based upon clinical considerations and
financial analysis. Those recommendations are presented
to the Illinois State Medical Society Committee on Drugs
and Therapeutics for their review and recommendations.
After the Committee on Drugs and Therapeutics makes their
recommendations, the department announces the Preferred
Drug List decisions.
To request the Illinois Medical Assurance Supplemental Rebate Offer Form to be sent to you to be completed, please submit an e-mail to request Pharmacy Rebate Offer Form or download the Illinois Medical Assistance Supplemental Rebate Offer Form below.
You may register to receive E-mail notification, when a
new Preferred Drug List is posted to the Web site, by completing
the form for Preferred Drug List E-mail
Notification Request.
Inquiries regarding the PDL should be sent via e-mail to Pharmacy.
|